Citations (76)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Rhodri Saunders, Rafael Torrejon Torres & Lawrence Konsinski. (2019) Evaluating the clinical and economic consequences of using video capsule endoscopy to monitor Crohn’s disease. Clinical and Experimental Gastroenterology 12, pages 375-384.
Read now
Read now
Vendel Kristensen, Trine Lauritzen, Lars-Petter Jelsness-JØrgensen & BjØrn Moum. (2015) Validation of a new extraction device for measuring faecal calprotectin in inflammatory bowel disease, and comparison to established extraction methods. Scandinavian Journal of Clinical and Laboratory Investigation 75:5, pages 355-361.
Read now
Read now
Krisztina B. Gecse, Johannan F. Brandse, Sandra van Wilpe, Mark Löwenberg, Cyriel Ponsioen, Gijs van den Brink & Geert D’Haens. (2015) Impact of disease location on fecal calprotectin levels in Crohn’s disease. Scandinavian Journal of Gastroenterology 50:7, pages 841-847.
Read now
Read now
Paul A. S. Olsen, Reidar Fossmark & Gunnar Qvigstad. (2015) Fecal calprotectin in patients with suspected small bowel disease – a selection tool for small bowel capsule endoscopy?. Scandinavian Journal of Gastroenterology 50:3, pages 272-277.
Read now
Read now
Charlotte M. Höög, Lars-Åke Bark, Olle Broström & Urban Sjöqvist. (2014) Capsule endoscopic findings correlate with fecal calprotectin and C-reactive protein in patients with suspected small-bowel Crohn’s disease. Scandinavian Journal of Gastroenterology 49:9, pages 1084-1090.
Read now
Read now
Roberta Caccaro, Renata D’Incà, Surajit Pathak & Giacomo Carlo Sturniolo. (2012) Clinical utility of calprotectin and lactoferrin in patients with inflammatory bowel disease: is there something new from the literature?. Expert Review of Clinical Immunology 8:6, pages 579-585.
Read now
Read now
Clas-Göran af Björkesten, Urpo Nieminen, Ulla Turunen, Perttu Arkkila, Taina Sipponen & Martti Färkkilä. (2012) Surrogate markers and clinical indices, alone or combined, as indicators for endoscopic remission in anti-TNF-treated luminal Crohn's disease. Scandinavian Journal of Gastroenterology 47:5, pages 528-537.
Read now
Read now
Articles from other publishers (69)
Myung‐won You, Sung Kyoung Moon, Yong Dae Lee, Shin Ju Oh, Seong Jin Park & Chang Kyun Lee. (2023) Assessing Active Bowel Inflammation in Crohn's Disease Using Intestinal Ultrasound. Journal of Ultrasound in Medicine 42:12, pages 2791-2802.
Crossref
Crossref
Yury A. Shelygin, Vladimir T. IvashkinSergey I. Achkasov, Igor V. ReshetovIgor V. Maev, Elena A. Belousova, Armen V. Vardanyan, Bella A. Nanaeva, Leila V. Adamyan, Oksana M. Drapkina, Leila S. Namazova-Baranova, Aleksandr Yu. RazumovskyAmiran Sh. Revishvili, Igor E. Khatkov, Aleksey V. Shabunin, Maria A. Livzan, Aleksandr V. SazhinVil M. Timerbulatov, Olga V. Khlynova, Diana I. Abdulganieva, Rustem A. Abdulkhakov, Timofey L. Aleksandrov, Olga P. Alekseeva, Sergey A. Alekseenko, Ivan S. Anosov, Igor G. Bakulin, Olga Yu. Barysheva, Kirill V. BolikhovViktor V. Veselov, Oleg V. Golovenko, Irina V. Gubonina, Anastasia I. Dolgushina, Tatiana N. Zhigalova, Anna V. Kagramanova, Vladimir N. Kashnikov, Oleg V. Knyazev, Nikolay V. Kostenko, Aleksey A. Likutov, Ekaterina Y. Lomakina, Irina D. Loranskaya, Airat F. Mingazov, Aleksey I. Moskalev, Ilya V. Nazarov, Natalia V. Nikitina, Alfia H. Odintsova, Vitaly V. Omelyanovsky, Marina F. Osipenko, Аndrey V. Оshchepkov, Vladimir V. Pavlenko, Elena A. PoluektovaGrigory V. RodomanAnastasia M. Segal, Stanislav I. Sitkin, Maria I. Skalinskaya, Andrey N. Surkov, Oleg I. Sushkov, Larisa V. Tarasova, Yulia B. UspenskayaSergey A. Frolov, Elena Yu. Chashkova, Oleg S. ShifrinOlga V. ShcherbakovaOksana B. Shchukina, Tatiana V. Shkurko & P. A. Makarchuk. (2023) Clinical guidelines. Crohn’s disease (К50), adults. Koloproktologia 22:3, pages 10-49.
Crossref
Crossref
Valeria Carnazzo, Serena Redi, Valerio Basile, Patrizia Natali, Francesca Gulli, Francesco Equitani, Mariapaola Marino & Umberto Basile. (2023) Calprotectin: two sides of the same coin. Rheumatology.
Crossref
Crossref
Junrong Li, Mingyang Xu, Wei Qian, Fangmei Ling, Yidong Chen, Shuang Li, Yiyu Cheng & Liangru Zhu. (2023) Clinical value of fecal calprotectin for evaluating disease activity in patients with Crohn’s disease. Frontiers in Physiology 14.
Crossref
Crossref
Sanja Dragašević, Milica Stojković-Lalošević, Andreja Nikolić, Nikola Panić & Vladimir Milivojević. (2023) Is fecal calprotectin a dependable indicator of activity in inflammatory bowel diseases?. Medicinska istrazivanja 56:4, pages 35-40.
Crossref
Crossref
Eugenia Veronica Di Brizzi, Annachiara Rocco, Graziella Babino, Dario Buononato, Giuseppe Argenziano & Anna Balato. (2022) Evaluation of the Role of Faecal Calprotectin in the Management of Psoriatic Patients under Treatment with Biologic Drugs. Biomedicines 10:11, pages 2968.
Crossref
Crossref
Shengnan Wang, Shijian Miao, Xiaoxia Qiu, Jie Wu & Yuhuan Wang. (2022) Fecal calprotectin in predicting small bowel capsule endoscopy findings in pediatric patients with known Crohn’s disease. Medicine 101:42, pages e31163.
Crossref
Crossref
Cristina Romero-Mascarell, Gloria Fernández-Esparrach, Cristina Rodríguez-De Miguel, Maria Carme Masamunt, Sonia Rodríguez, Jordi Rimola, Miguel Urpí, Gherzon Simon Casanova, Ingrid Ordás, Elena Ricart, Berta Caballol, Agnès Fernández-Clotet, Julià Panés, Josep Llach & Begoña González-Suárez. (2022) Fecal Calprotectin for Small Bowel Crohn’s Disease: Is It a Cutoff Issue?. Diagnostics 12:9, pages 2226.
Crossref
Crossref
Adriaan G. Volkers, Laura Appleton, Richard B. Gearry, Christopher M. Frampton, Floris A. E. de Voogd, Annemieke M. Peters van Ton, Steven T. Leach, Daniel A. Lemberg & Andrew S. Day. (2022) Fecal Calprotectin, Chitinase 3-Like-1, S100A12 and Osteoprotegerin as Markers of Disease Activity in Children with Crohn’s Disease. Gastrointestinal Disorders 4:3, pages 180-189.
Crossref
Crossref
Floris De Voogd, Harshad Joshi, Elsa Van Wassenaer, Steven Bots, Geert D’Haens & Krisztina Gecse. (2022) Intestinal Ultrasound to Evaluate Treatment Response During Pregnancy in Patients With Inflammatory Bowel Disease. Inflammatory Bowel Diseases 28:7, pages 1045-1052.
Crossref
Crossref
Aisha Abo El Ela, Nina Meuli, Petr Hruz & Emanuel Burri. (2022) Faecal calprotectin increases the diagnostic yield in patients with suspected small bowel disease – a multicenter retrospective cohort study. Swiss Medical Weekly 153:3, pages 40050.
Crossref
Crossref
Yang Pan, Dan Wang & Fan Liu. (2022) miR-146b suppresses LPS-induced M1 macrophage polarization via inhibiting the FGL2-activated NF-κB/MAPK signaling pathway in inflammatory bowel disease. Clinics 77, pages 100069.
Crossref
Crossref
Gujjarlapudi Deepika, Namburu Veeraiah, Syed Hassan Naveed & D. Nageshwar Reddy. (2021) Fecal Calprotectin as early predictor for screening and relapse in pediatric chronic diarrhea in India. IP International Journal of Medical Paediatrics and Oncology 7:4, pages 178-184.
Crossref
Crossref
Humaira Rashid, Towfida J. Siddiqua, Biplob Hossain, Abdullah Siddique, Mamun Kabir, Zannatun Noor, Masud Alam, Mamun Ahmed & Rashidul Haque. (2021) MicroRNA Expression and Intestinal Permeability in Children Living in a Slum Area of Bangladesh. Frontiers in Molecular Biosciences 8.
Crossref
Crossref
Eun Suk Jung, Sang Pyo Lee, Sea Hyub Kae, Jung Han Kim, Hyeong Su Kim & Hyun Joo Jang. (2021) Diagnostic Accuracy of Fecal Calprotectin for the Detection of Small Bowel Crohn's Disease through Capsule Endoscopy: An Updated Meta-Analysis and Systematic Review. Gut and Liver 15:5, pages 732-741.
Crossref
Crossref
Nicolas Pierre, Catherine Salée, Sophie Vieujean, Emeline Bequet, Angela‐Maria Merli, Britta Siegmund, Marie‑Alice Meuwis & Edouard Louis. (2021) Review article: distinctions between ileal and colonic Crohn's disease: from physiology to pathology. Alimentary Pharmacology & Therapeutics 54:6, pages 779-791.
Crossref
Crossref
Jéssica A. Barbosa, Lucas A. Rodrigues, Daniel A. Columbus, Juan C. P. Aguirre, John C. S. Harding, Vinícius S. Cantarelli & Matheus de O. Costa. (2021) Experimental infectious challenge in pigs leads to elevated fecal calprotectin levels following colitis, but not enteritis. Porcine Health Management 7:1.
Crossref
Crossref
Laura Dumitrescu, Daciana Marta, Adela Dănău, Antonia Lefter, Delia Tulbă, Liviu Cozma, Emilia Manole, Mihaela Gherghiceanu, Laura Cristina Ceafalan & Bogdan Ovidiu Popescu. (2021) Serum and Fecal Markers of Intestinal Inflammation and Intestinal Barrier Permeability Are Elevated in Parkinson’s Disease. Frontiers in Neuroscience 15.
Crossref
Crossref
Anthony Buisson, Wing Yan Mak, Michael J AndersenJrJr, Donald Lei, Joel Pekow, Russell D Cohen, Stacy A Kahn, Bruno Pereira & David T Rubin. (2021) Fecal Calprotectin Is Highly Effective to Detect Endoscopic Ulcerations in Crohn’s Disease Regardless of Disease Location. Inflammatory Bowel Diseases 27:7, pages 1008-1016.
Crossref
Crossref
Ferdinando D’Amico, Stéphane Nancey, Silvio Danese & Laurent Peyrin-Biroulet. (2021) A Practical Guide for Faecal Calprotectin Measurement: Myths and Realities. Journal of Crohn's and Colitis 15:1, pages 152-161.
Crossref
Crossref
Bruno Lima Rodrigues, Márcia Carolina Mazzaro, Cristiane Kibune Nagasako, Maria de Lourdes Setsuko Ayrizono, João José Fagundes & Raquel Franco Leal. (2020) Assessment of disease activity in inflammatory bowel diseases: Non-invasive biomarkers and endoscopic scores. World Journal of Gastrointestinal Endoscopy 12:12, pages 504-520.
Crossref
Crossref
Fatemeh Khaki-Khatibi, Durdi Qujeq, Mehrdad Kashifard, Soheila Moein, Mahmood Maniati & Mostafa Vaghari-Tabari. (2020) Calprotectin in inflammatory bowel disease. Clinica Chimica Acta 510, pages 556-565.
Crossref
Crossref
Eran Zittan, Ian M. Gralnek & Marc S. Berns. (2020) The New Proactive Approach and Precision Medicine in Crohn’s Disease. Biomedicines 8:7, pages 193.
Crossref
Crossref
José Germán Sánchez-Hernández, Jonás Samuel Pérez-Blanco, Noemí Rebollo, Fernando Muñoz, Vanessa Prieto & María Victoria Calvo. (2020) Biomarkers of disease activity and other factors as predictors of adalimumab pharmacokinetics in inflammatory bowel disease. European Journal of Pharmaceutical Sciences 150, pages 105369.
Crossref
Crossref
Runqing Li, Xiuying Zhao, Jingxiao Dong, Dong Zhu, Tengjiao Wang, Song Yang, Zhipeng Zhao & Nan Xiao. (2019) Evaluation of a fluorescent immunochromatography test for fecal calprotectin. Journal of Clinical Laboratory Analysis 34:2.
Crossref
Crossref
Bingjie Xiang, Ziyuan Dong & Cong Dai. (2020) The diagnostic and predictive value of Fecal calprotectin and capsule endoscopy for small-bowel Crohn�s disease: A systematic review and meta-analysis. Revista Española de Enfermedades Digestivas.
Crossref
Crossref
Anneline Cremer, Jade Ku, Leila Amininejad, Marie-Rose Bouvry, Fabian Brohet, Claire Liefferinckx, Jacques Devière, André van Gossum, Julie Smet, Patrick Stordeur & Denis Franchimont. (2019) Variability of Faecal Calprotectin in Inflammatory Bowel Disease Patients: An Observational Case-control Study. Journal of Crohn's and Colitis 13:11, pages 1372-1379.
Crossref
Crossref
Ebby George Simon, Richard Wardle, Aye Aye Thi, Jeanette Eldridge, Sunil Samuel & Gordon William Moran. (2019) Does fecal calprotectin equally and accurately measure disease activity in small bowel and large bowel Crohn’s disease?: a systematic review. Intestinal Research 17:2, pages 160-170.
Crossref
Crossref
Christian Maaser, Andreas Sturm, Stephan R Vavricka, Torsten Kucharzik, Gionata Fiorino, Vito Annese, Emma Calabrese, Daniel C Baumgart, Dominik Bettenworth, Paula Borralho Nunes, Johan Burisch, Fabiana Castiglione, Rami Eliakim, Pierre Ellul, Yago González-Lama, Hannah Gordon, Steve Halligan, Konstantinos Katsanos, Uri Kopylov, Paulo G Kotze, Eduards Krustiņš, Andrea Laghi, Jimmy K Limdi, Florian Rieder, Jordi Rimola, Stuart A Taylor, Damian Tolan, Patrick van Rheenen, Bram Verstockt & Jaap Stoker. (2019) ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications. Journal of Crohn's and Colitis 13:2, pages 144-164K.
Crossref
Crossref
Amanda M. Lynn & Edward V. LoftusJrJr. 2019. Biomarkers in Inflammatory Bowel Diseases. Biomarkers in Inflammatory Bowel Diseases
57
71
.
Jordi Guardiola, Triana Lobatón, Elena Cerrillo, Rocío Ferreiro-Iglesias, Javier P. Gisbert, Eugeni Domènech, María Chaparro, Maria Esteve & Francisco Rodríguez-Moranta. (2018) Recomendaciones del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) sobre la utilidad de la determinación de calprotectina fecal en la enfermedad inflamatoria intestinal. Gastroenterología y Hepatología 41:8, pages 514-529.
Crossref
Crossref
Jordi Guardiola, Triana Lobatón, Elena Cerrillo, Rocío Ferreiro-Iglesias, Javier P. Gisbert, Eugeni Domènech, María Chaparro, Maria Esteve & Francisco Rodríguez-Moranta. (2018) Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the utility of the determination of faecal calprotectin in inflammatory bowel disease. Gastroenterología y Hepatología (English Edition) 41:8, pages 514-529.
Crossref
Crossref
Eran Zittan, Orlaith B Kelly, Ian M Gralnek, Mark S Silverberg & A Hillary Steinhart. (2018) Fecal calprotectin correlates with active colonic inflammatory bowel disease but not with small intestinal Crohn's disease activity. JGH Open 2:5, pages 201-206.
Crossref
Crossref
Sara Monteiro, Mara Barbosa, Tiago Cúrdia Gonçalves, Pedro Boal Carvalho, Maria João Moreira, Bruno Rosa & José Cotter. (2018) Fecal Calprotectin as a Selection Tool for Small Bowel Capsule Endoscopy in Suspected Crohn’s Disease. Inflammatory Bowel Diseases 24:9, pages 2033-2038.
Crossref
Crossref
Anthony Buisson, Emilie Vazeille, Régine Minet-Quinard, Marion Goutte, Damien Bouvier, Félix Goutorbe, Bruno Pereira, Nicolas Barnich & Gilles Bommelaer. (2018) Fecal Matrix Metalloprotease-9 and Lipocalin-2 as Biomarkers in Detecting Endoscopic Activity in Patients With Inflammatory Bowel Diseases. Journal of Clinical Gastroenterology 52:7, pages e53-e62.
Crossref
Crossref
Che-Yung Chao, Carl Frederic Duchatellier & Ernest G. Seidman. (2018) Unsuspected Small-Bowel Crohn’s Disease in Elderly Patients Diagnosed by Video Capsule Endoscopy. Diagnostic and Therapeutic Endoscopy 2018, pages 1-7.
Crossref
Crossref
Christopher Ma, Rowan Lumb, Emily V. Walker, Rae R. Foshaug, ThucNhi T. Dang, Sanam Verma, Vivian W. Huang, Karen I. Kroeker, Karen Wong, Levinus A. Dieleman, Richard N. Fedorak & Brendan P. Halloran. (2017) Noninvasive Fecal Immunochemical Testing and Fecal Calprotectin Predict Mucosal Healing in Inflammatory Bowel Disease. Inflammatory Bowel Diseases 23:9, pages 1643-1649.
Crossref
Crossref
Daniël R. Hoekman, Judith Zeevenhooven, Geert R. D’Haens & Marc A. Benninga. (2017) The prevalence of irritable bowel syndrome-type symptoms in inflammatory bowel disease patients in remission. European Journal of Gastroenterology & Hepatology 29:9, pages 1086-1090.
Crossref
Crossref
Anthony Buisson, Florent Gonzalez, Florian Poullenot, Stéphane Nancey, Elisa Sollellis, Mathurin Fumery, Benjamin Pariente, Mathurin Flamant, Caroline Trang-Poisson, Guillaume Bonnaud, Stéphane Mathieu, Alain Thevenin, Marc Duruy, Jérôme Filippi, François Lʼhopital, Fabrice Luneau, Véronique Michalet, Julien Genès, Anca Achim, Emmanuelle Cruzille, Gilles Bommelaer, David Laharie, Laurent Peyrin-Biroulet, Bruno Pereira, Maria Nachury & Guillaume Bouguen. (2017) Comparative Acceptability and Perceived Clinical Utility of Monitoring Tools. Inflammatory Bowel Diseases 23:8, pages 1425-1433.
Crossref
Crossref
Alexandre Loktionov, Vivek Chhaya, Tatiana Bandaletova & Andrew Poullis. (2017) Inflammatory bowel disease detection and monitoring by measuring biomarkers in non-invasively collected colorectal mucus. Journal of Gastroenterology and Hepatology 32:5, pages 992-1002.
Crossref
Crossref
K. Diederen, D. R. Hoekman, A. Leek, V. M. Wolters, T. Z. Hummel, T. G. de Meij, B. G. P. Koot, M. M. Tabbers, M. A. Benninga & A. Kindermann. (2017) Raised faecal calprotectin is associated with subsequent symptomatic relapse, in children and adolescents with inflammatory bowel disease in clinical remission. Alimentary Pharmacology & Therapeutics 45:7, pages 951-960.
Crossref
Crossref
Saranya Kittanakom, Md. Sharif Shajib, Kristine Garvie, Joceline Turner, Dan Brooks, Sufian Odeh, Robert Issenman, V. Tony Chetty, Joseph Macri & Waliul I. Khan. (2017) Comparison of Fecal Calprotectin Methods for Predicting Relapse of Pediatric Inflammatory Bowel Disease. Canadian Journal of Gastroenterology and Hepatology 2017, pages 1-10.
Crossref
Crossref
Khadija H. Chaudrey & Edward V. LoftusJr.Jr.. 2017. Inflammatory Bowel Disease. Inflammatory Bowel Disease
45
59
.
Murat Cikot, Kivanc Derya Peker, Mehmet Abdussamet Bozkurt, Ali Kocatas, Osman Kones, Sinan Binboga, Asuman Gedikbasi & Halil Alis. (2016) Plasma calprotectin level: usage in distinction of uncomplicated from complicated acute appendicitis. World Journal of Emergency Surgery 11:1.
Crossref
Crossref
Melissa F. Hale, Kaye Drew, Mark E. McAlindon & Reena Sidhu. (2016) The diagnostic accuracy of faecal calprotectin and small bowel capsule endoscopy and their correlation in suspected isolated small bowel Crohn’s disease. European Journal of Gastroenterology & Hepatology 28:10, pages 1145-1150.
Crossref
Crossref
Uri Kopylov, Diana E. Yung, Tal Engel, Tomer Avni, Robert Battat, Shomron Ben-Horin, John N. Plevris, Rami Eliakim & Anastasios Koulaouzidis. (2016) Fecal calprotectin for the prediction of small-bowel Crohn’s disease by capsule endoscopy. European Journal of Gastroenterology & Hepatology 28:10, pages 1137-1144.
Crossref
Crossref
Anastasios Koulaouzidis, Taina Sipponen, Artur Nemeth, Richard Makins, Uri Kopylov, Moshe Nadler, Andry Giannakou, Diana E. Yung, Gabriele Wurm Johansson, Leonidas Bartzis, Henrik Thorlacius, Ernest G. Seidman, Rami Eliakim, John N. Plevris & Ervin Toth. (2016) Association Between Fecal Calprotectin Levels and Small-bowel Inflammation Score in Capsule Endoscopy: A Multicenter Retrospective Study. Digestive Diseases and Sciences 61:7, pages 2033-2040.
Crossref
Crossref
A. Buisson, E. Vazeille, R. Minet‐Quinard, M. Goutte, D. Bouvier, F. Goutorbe, B. Pereira, N. Barnich & G. Bommelaer. (2016) Faecal chitinase 3‐like 1 is a reliable marker as accurate as faecal calprotectin in detecting endoscopic activity in adult patients with inflammatory bowel diseases. Alimentary Pharmacology & Therapeutics 43:10, pages 1069-1079.
Crossref
Crossref
Emily K. Wright, Michael A. Kamm, Peter De Cruz, Amy L. Hamilton, Kathryn J. Ritchie, Jacqueline I. Keenan, Steven Leach, Laura Burgess, Alan Aitchison, Alexandra Gorelik, Danny Liew, Andrew S. Day & Richard B. Gearry. (2016) Comparison of Fecal Inflammatory Markers in Crohnʼs Disease. Inflammatory Bowel Diseases 22:5, pages 1086-1094.
Crossref
Crossref
F. Goutorbe, M. Goutte, R. Minet-Quinard, A-L. Boucher, B. Pereira, G. Bommelaer & A. Buisson. (2015) Endoscopic Factors Influencing Fecal Calprotectin Value in Crohn’s Disease. Journal of Crohn's and Colitis 9:12, pages 1113-1119.
Crossref
Crossref
Gil Y. Melmed & Stephan R. Targan. 2015. Yamada' s Textbook of Gastroenterology. Yamada' s Textbook of Gastroenterology
1418
1449
.
Lorete Maria da Silva KOTZE, Renato Mitsunori NISIHARA, Sandra Beatriz MARION, Murilo Franco CAVASSANI & Paulo Gustavo KOTZE. (2015) FECAL CALPROTECTIN: levels for the ethiological diagnosis in Brazilian patients with gastrointestinal symptoms. Arquivos de Gastroenterologia 52:1, pages 50-54.
Crossref
Crossref
Kayalvily Jesuratnam-Nielsen, Vibeke B. Løgager, Pia Munkholm, Yousef W. Nielsen & Henrik S. Thomsen. (2015) Comparison of a New Magnetic Resonance Imaging Protocol and Magnetic Resonance Follow-Through in Patients with Inflammatory Bowel Disease—A Prospective Pilot Study. Open Journal of Radiology 05:02, pages 117-124.
Crossref
Crossref
M. F. Osipenko, M. A. Livzan, M. I. Skalinskaya & E. A. Lyalyukova. (2015) Fecal calprotectin concentration in the differential diagnosis of bowel diseases. Terapevticheskii arkhiv 87:2, pages 30.
Crossref
Crossref
Frank S. Lehmann, Emanuel Burri & Christoph Beglinger. (2014) The role and utility of faecal markers in inflammatory bowel disease. Therapeutic Advances in Gastroenterology 8:1, pages 23-36.
Crossref
Crossref
Dejan Micic, Atsushi Sakuraba & Russell D. Cohen. 2015. Inflammatory Bowel Disease. Inflammatory Bowel Disease
59
71
.
Luisa Guidi, Manuela Marzo, Gianluca Andrisani, Carla Felice, Daniela Pugliese, Giammarco Mocci, Olga Nardone, Italo De Vitis, Alfredo Papa, Gianlodovico Rapaccini, Franca Forni & Alessandro Armuzzi. (2014) Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year. Digestive and Liver Disease 46:11, pages 974-979.
Crossref
Crossref
Emily K. Wright, Peter De Cruz, Richard Gearry, Andrew S. Day & Michael A. Kamm. (2014) Fecal Biomarkers in the Diagnosis and Monitoring of Crohnʼs Disease. Inflammatory Bowel Diseases 20:9, pages 1668-1677.
Crossref
Crossref
Uri Kopylov, Greg Rosenfeld, Brian Bressler & Ernest Seidman. (2014) Clinical Utility of Fecal Biomarkers for the Diagnosis and Management of Inflammatory Bowel Disease. Inflammatory Bowel Diseases 20:4, pages 742-756.
Crossref
Crossref
Federico Argüelles-Arias, Juan Rodríguez-Oballe, Calixto Duarte-Chang, Luisa Castro-Laria, Josefa María García-Montes, Ángel Caunedo-Álvarez & Juan Manuel Herrerías-Gutiérrez. (2014) Capsule Endoscopy in the Small Bowel Crohn’s Disease. Gastroenterology Research and Practice 2014, pages 1-8.
Crossref
Crossref
Triana Lobatón, Alicia López-García, Francisco Rodríguez-Moranta, Alexandra Ruiz, Lorena Rodríguez & Jordi Guardiola. (2013) A new rapid test for fecal calprotectin predicts endoscopic remission and postoperative recurrence in Crohn's disease. Journal of Crohn's and Colitis 7:12, pages e641-e651.
Crossref
Crossref
Froukje J. Verdam, Susana Fuentes, Charlotte de Jonge, Erwin G. Zoetendal, Runi Erbil, Jan Willem Greve, Wim A. Buurman, Willem M. de Vos & Sander S. Rensen. (2013) Human intestinal microbiota composition is associated with local and systemic inflammation in obesity. Obesity 21:12, pages E607-E615.
Crossref
Crossref
Gerhard Rogler, Xavier Aldeguer, Wolfgang Kruis, Anders Lasson, Ulrich Mittmann, Ken Nally, Laurent Peyrin-Biroulet, Alain Schoepfer, Morten Vatn, Stephan Vavricka & Robert Logan. (2013) Concept for a rapid point-of-care calprotectin diagnostic test for diagnosis and disease activity monitoring in patients with inflammatory bowel disease: Expert clinical opinion. Journal of Crohn's and Colitis 7:8, pages 670-677.
Crossref
Crossref
Liselotte Coorevits, Filip J. Baert & Hilde J.M. Vanpoucke. (2013) Faecal calprotectin: comparative study of the Quantum Blue rapid test and an established ELISA method. Clinical Chemistry and Laboratory Medicine (CCLM) 51:4, pages 825-831.
Crossref
Crossref
Hirokazu YamagamiKenji WatanabeNoriko KamataMitsue SogawaTetsuo Arakawa. (2013) Small Bowel Endoscopy in Inflammatory Bowel Disease. Clinical Endoscopy 46:4, pages 321.
Crossref
Crossref
Kaija-Leena Kolho, Henrik Alfthan & Esa Hämäläinen. (2012) Effect of Bowel Cleansing for Colonoscopy on Fecal Calprotectin Levels in Pediatric Patients. Journal of Pediatric Gastroenterology & Nutrition 55:6, pages 751-753.
Crossref
Crossref
KL Kolho, D. Turner, G. Veereman-Wauters, M. Sladek, L. de Ridder, R. Shaoul, A. Paerregaard, J. Amil Dias, S. Koletzko, F. Nuti, Y. Bujanover, A. Staiano, K. Bochenek, L. Finnby, A. Levine & G. Veres. (2012) Rapid Test for Fecal Calprotectin Levels in Children With Crohn Disease. Journal of Pediatric Gastroenterology & Nutrition 55:4, pages 436-439.
Crossref
Crossref
Anastasios Koulaouzidis, Sarah Douglas & John N. Plevris. (2011) Lewis Score Correlates More Closely with Fecal Calprotectin Than Capsule Endoscopy Crohn’s Disease Activity Index. Digestive Diseases and Sciences 57:4, pages 987-993.
Crossref
Crossref
Anastasios Koulaouzidis. (2012) Blue mode does not offer any benefit over white light when calculating Lewis score in small-bowel capsule endoscopy. World Journal of Gastrointestinal Endoscopy 4:2, pages 33.
Crossref
Crossref